Restless Legs Syndrome — RLS and Cancer
No Cover

Restless Legs Syndrome — RLS and Cancer

Khosro Hekmat

Restless legs during cancer care: what is missing is the question.

"I have cancer. I am hardly going to come in about my legs." Restless legs syndrome is rarely asked about during cancer care, because in cancer there is already an explanation for every restless night: the worry, the steroids, the nausea, the pain, the exhaustion. The guideline of the European Society for Medical Oncology includes RLS among the orphan symptoms, which it defines as symptoms not regularly assessed in clinical practice.

In two small studies from one Italian research group during cancer drug treatment, a sleep medicine specialist confirmed RLS in 36 of 173 people (20.8%) and in 47 of 257 (18.3%). Six months after the end of chemotherapy, 25 of the 36 could be reassessed, and in 4 of them the symptoms persisted, although follow-up was incomplete. The iron results are often already available. They are simply interpreted in relation to anaemia rather than RLS symptoms. Ferritin rises with inflammation, so in cancer a second test is needed. In this series, a ferritin at or below 100 µg/l is the threshold at which iron treatment should be discussed. It is not a target value. Transferrin saturation is always measured alongside.

The book explains which medicines used during cancer treatment can trigger or worsen RLS symptoms, antiemetics first among them, and how RLS can be told apart from nerve damage from chemotherapy, akathisia, fatigue, pain and cramps. On two questions that trouble many people, whether restless legs syndrome or its medicines raise the risk of cancer, it sets out what the studies show and what they cannot show. The final chapter reaches through to palliative care, including options when swallowing is no longer possible. According to the ESMO guideline, no treatment studies of RLS had been carried out in people with cancer, so most treatment advice is extrapolated from studies of RLS in general.

WHAT IS IN THE BOOK
- How common RLS is in cancer, and why these figures must be read with caution
- Iron deficiency as one possible contributor, and why ferritin can mislead in cancer
- Chemotherapy, antiemetics and the other concomitant medicines
- Hormone treatment, the blood disorders and stem cell transplantation
- Nerve damage from chemotherapy
- Fatigue, insomnia, pain, cramps and akathisia: conditions that can mimic RLS
- Opioids: treatment, withdrawal and confusion
- Diagnosis in oncology, and treatment through to palliative care

WHO THIS BOOK IS FOR
For people during or after cancer treatment whose nights are restless, for their relatives, and for medical and nursing staff in oncology and palliative care.

ABOUT THE SERIES
Volume 33 of 52 in the book series on restless legs syndrome, part "RLS with Other Conditions". Every volume can be read on its own. The statements in this volume rest on 202 professional sources, each one listed individually in the reference section.

Book Info

Publisher Khosro Hekmat
Release Date 2026-10-23
Page Count 260 Pages
File Size 1.3 MB
Language en-US
ISBN 9798237942392

No download link available yet. You can .

Related Books

Similar recommendations you might enjoy

Join Telegram